Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
- 2 June 2003
- Vol. 21 (19-20) , 2468-2473
- https://doi.org/10.1016/s0264-410x(03)00033-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Semiautomation of Multilocus Sequence Typing for the Characterization of Clinical Isolates of Neisseria meningitidisJournal of Clinical Microbiology, 2001
- Introduction of an automated service for the laboratory confirmation of meningococcal disease in ScotlandJournal of Clinical Pathology, 2001
- Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulationsVaccine, 2000
- Multilocus sequence typingTrends in Microbiology, 1999
- Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteinsVaccine, 1999
- Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6Epidemiology and Infection, 1999
- Sequencing ofporAfrom clinical isolates ofNeisseria meningitidisdefines a subtyping scheme and its genetic regulationCanadian Journal of Microbiology, 1998
- Neisseria meningitidis: vaccines and vaccine candidatesJournal of Infection, 1996
- Antibodies to Polysialic Acid and its N-Propyl Derivative: Binding Properties and Interaction with Human Embryonal Brain GlycopeptidesThe Journal of Infectious Diseases, 1995
- Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidisMolecular Microbiology, 1991